The global women’s health market size stood at around USD 32 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.
Women’s health includes all of the therapeutics, drugs, and surgical offerings precautionary measures for the various disorders associated with the women population. These disorders vary from nutrition, oncology, reproductive, menopause, urological as well as other healthcare applications. Women’s health is focused on providing better management of diseases and improving the overall health of women population.
Increasing prevalence of preventing women related health disorders by the population and authorities is expected to promote the market value. Rise in the levels of research & development initiatives undertaken by various manufacturers in providing better healthcare services for women is expected to positively affect the growth of the market as well. Lack of qualitative healthcare services for women from the under-developed regions of the world is expected to provide better areas for growth of the market value. Changes in the lifestyle of individuals coupled with bad nutritional intake are factors driving the growth of the market.
Major Women’s Health Disease Indication
The women’s health market has been segmented into postmenopausal osteoporosis, menopause, endometriosis, contraceptives, hormonal infertility, and polycystic ovary syndrome (PCOS). The postmenopausal osteoporosis segment accounted for one of the largest shares of the market in 2019, due to the growing population of women aged 40 and above and the launch of various drugs to cure menopausal osteoporosis and improve health.
The hormonal infertility segment is expected to grow rapidly owing to high fertility-related conditions in developed countries. Moreover, the easy availability of several medicines to cure hormonal imbalance and market players’ investments in new product development would drive the segment growth over the forecast period. Hormonal imbalance such as the imbalance of prolactin, estrogen, and thyroid is increasing in women due to factors such as stress, further driving the demand for medication to improve health.